The ABM Playbook Hospital Systems Actually Need (And the Myths Getting in the Way) | NPLUS Global

Most account-based marketing frameworks were written with a mid-market SaaS buyer in mind: one building, one budget line, three to five people in a Slack channel making a decision together. Hospital systems don't work that way, and yet a lot of ABM strategy aimed at healthcare gets imported wholesale from that world, then lightly relabeled with "IDN" and "health system" swapped in for "enterprise account."

The result is a set of assumptions that sound reasonable in a sales enablement deck but fall apart against the reality of a 14-hospital integrated delivery network with three regional CMIOs, a centralized supply chain team, and a physician advisory council that meets quarterly. These myths persist because they're operationally convenient — they let teams build simpler lead lists, simpler content calendars, simpler dashboards. Convenient isn't the same as accurate.

Myth: More contacts on your target account list means more pipeline coverage.

Fact: Volume without relationship mapping just multiplies noise. Adding fifty names from a health system to your ABM list doesn't matter if none of them sit inside the specific initiative you're trying to influence — a lab automation project, a revenue cycle overhaul, a population health push. What matters is identifying the four or five roles that actually touch that decision this fiscal year, and building around them deliberately rather than casting wide and hoping engagement data sorts it out later.

Myth: The C-suite signs off, so ABM should aim highest.

Fact: In most hospital systems, executives rarely initiate a purchase decision — they ratify one that's already been built by clinical and operational stakeholders underneath them. A CFO or CMIO typically enters the process once a director-level champion has already framed the problem, gathered internal support, and shaped the vendor shortlist. Campaigns aimed exclusively at the C-suite often arrive after the internal narrative has already hardened around a different vendor's language.

Myth: There's one buying committee that persists through the whole deal.

Fact: The committee reshapes itself at every stage — clinical evaluation, security and IT review, legal and procurement, finance sign-off — often with minimal handoff between groups. A clinical champion who was your strongest advocate in month one may have zero visibility into the security review happening in month four, and vice versa. Messaging built for one phase's audience frequently lands flat with the next phase's, because nobody adjusted the argument as the room changed.

Myth: Org charts and firmographic data are enough to map decision-makers.

Fact: Health system org structures are unusually unstable in public and third-party data because of constant M&A activity, service-line consolidation, and physician leadership turnover. A director who owned a decision eighteen months ago may now sit in a completely different facility under a different reporting line, or may have left the system entirely during the last merger cycle. This is part of why account intelligence for hospital targeting has to combine structural data with something closer to real-time signal — which is the gap firms like NPLUS Global exist to close, by triangulating org movement and engagement rather than relying on a static hierarchy snapshot.

Myth: Personalized ABM content needs to be built per contact.

Fact: At the scale of a multi-facility system, one-to-one personalization is a resourcing fantasy — nobody is writing sixty individualized emails for one account and sustaining it past the pilot phase. What holds up is segmenting by role-cluster and by the specific lens each stakeholder applies to the decision: clinical outcomes for physician leadership, workflow disruption for nursing and operations, total cost and risk for finance and procurement. Three or four well-built variants beat sixty shallow ones, and they're maintainable long after the campaign launch excitement wears off.

Myth: A closed deal is a secure account.

Fact: Integrated delivery networks have high internal churn — champions get promoted, reassigned, or poached; service lines get folded into new divisions; the whole system gets acquired or merges with another. A signed contract doesn't freeze the relationship map in place, and treating "closed-won" as the end of account monitoring is how vendors get blindsided when the person who championed the deal is suddenly running a different department, or a different hospital entirely. Post-sale, the same account-mapping discipline that won the deal needs to keep running quietly in the background.

Myth: Marketing and sales alignment means agreeing on shared KPIs.

Fact: Shared lead-scoring thresholds and MQL definitions are useful, but they're not what alignment actually requires in a hospital ABM motion. Real alignment means both teams can see, at any point, who from the account is engaging, from which facility, on which topic — because a director at the flagship hospital researching interoperability and a supply chain manager at a satellite facility researching pricing are not the same signal, even if they technically work for the same health system. Without that shared visibility into a genuinely multi-person, multi-facility buying group, sales chases whoever replied to an email while marketing optimizes for whoever downloaded a whitepaper, and neither one is necessarily talking to the person who'll actually move the deal forward.